Job application form First name* Last name* Email* Phone* Position* Address* LinkedIn URL * Portfolio or website URL Upload CV* Upload File Message Submit

Available online Meeting with Yasmine

Reliable sourcing and logistics for medical devices and ancillaries for trials, from equipment to print materials, with cost effective delivery and managed returns. As well as medications, clinical trials often require a wide variety of ancillary supplies. These include medical and technological equipment such as weighing scales, pill cutters and electrodes, disposable products, lab kits and print materials such as site files and pharmacy binders. At CSI, we apply our sourcing capabilities, logistical expertise and robust quality standards to ensure that all essential supplies reach trial sites in a reliable and cost-effective manner, no matter their location. We also handle the returns process, so that once a site or patient has completed the trial, all materials are sent back to the warehouses. Leveraging our partnerships with leading manufacturers, we can offer significant cost savings on ancillaries to support our partners’ clinical trials. Download our brochure to find out all of our comprehensive ancillaries services. Medical Devices and Ancillaries Download PDF Up to 60% on initial shipments Up to 40% on resupply shipments Up to 60% on broker fees (customs clearance) Case Study CSI’s ancillary services include the rapid delivery of Medical equipment Electrocardiogram (ECG) tests Spirometers Weighing scales Blood pressure monitors Infusion pumps Cooled or uncooled centrifuges Refrigerators Freezers with temperatures ranging from -20°C to -80°C Technological equipment eDiaries Mobile devices Laptops Printers Pill splitters Print materials Investigator site files Pharmacy binders Patient recruitment material Download our Ancillaires brochure

Browse our top comparator medicines with CoA, including leading oncology and biosimilar products, available through qualified global manufacturers and suppliers. Upcoming Events Stay up to date with where you can meet the CSI team next. Here you’ll find the conferences and industry events we’re attending, with dates, locations, and booth or session details. If you’re a sponsor, CRO, or CMO, book a meeting to discuss comparator sourcing, global clinical trial supply, and end-to-end logistics. Check back for updates or use the links below to schedule time with us. Schedule a meeting for our next event 11 December 2025 OCT New England CSI will be exhibiting at OCT New England in Boston on October 15th and 16th. Meet CSI's Project Management Associates Jessica Ianiro and Yasmine Clemson. Book a meeting 19 December 2025 Expopharm Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Book a meeting 11 November 2025 CTS Conference Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Book a meeting

CSI is headquartered in London and has offices in the United Kingdom, the United States, Germany and Israel, with partner warehouses in a further 20 countries. Locations Clinical Services International (CSI) has the global reach necessary to supply complex, adaptive clinical trials with medicines and ancillaries all over the world. Headquartered in London, with offices in the United Kingdom, Germany, United States and China, our experienced teams pride themselves on delivering efficient sourcing and project management solutions to serve global studies and to help improve patient outcomes. Our Offices United Kingdom Germany United States China Clinical Services International Ltd 50 Sloane Avenue Suite 212 London SW3 3DD United Kingdom info@csint.com +44 (0)203 954 0517 CSI Clinical Services International GmbH Hannoversche Straße 2 10115 Berlin Germany info@csint.com +49 (0)30 2843 0782 Clinical Services International LLC 795 Horsham Road Horsham PA 19044 United States info@csint.com +1 (267) 267 3993 Clinical Services International Room 1501 & 1508 699 West Nanjing Road Jing’an District Shanghai 中国上海市静安区南京西路699号 1501室 & 1508室 info@csint.com + 86 21 3100 7900 ext. 168 16px Title - - - - Our Global Reach Warehouses and offices Our network extends to 60 countries on six continents Contact us Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements Company type Submit

Export of expensive comparators from Europe to China with first leg documents and streamlined approach More case studies Ensuring batch-consistent, compliant comparator supply across NA, EU, and APAC - on time and uninterrupted. Read all Effective Sourcing of Semaglutide for a Global Phase III Clinical Trial From supply shortfall to on-time first-patient-first-visit across Europe, delivered in three days. Read all CSI's 72-hour Abraxane Rescue Mission Adaptive, multi-product supply across 22 countries and 80 sites, kept on time, in budget and compliant. Read all CSI’s Expert Delivery of a Global Respiratory Study A leading global biopharmaceutical company urgently requested CSI to supply the Fluarix QIV Southern Hemisphere Vaccine for 2025. Read all Rapid Sourcing of Discontinued Southern Hemisphere Vaccine for a Global Biopharmaceutical Client Securing reliable, cost-effective, long-term supply of Eylea PFS from EU and USA for a global biotech company’s clinical studies. Read all Securing Long-Term, Cost-Effective Supply of Eylea EU & USA for programs of studies A biotech client asked CSI to source Lucentis for a Phase II ophthalmology trial. Read all Comparator Sourcing for a Phase II Ophthalmology Study CSI Efficiently Delivered Venetoclax and Azacitidine Across 17 Countries Read all How CSI streamlined Venetoclax and Azacitidine supply across 17 countries in record time CSI’s flexible approach to global distribution ensured a large CRO's five-year and three-year studies across a total of 18 countries could proceed without delay Read all Global Device Distribution How CSI rescued an oncology trial when a competitor failed to deliver, despite an extremely tight deadline and scarce supply on the market Read all Rescuing a Global CRO's Oncology Study with Cetuximab How CSI fulfilled what our competitors couldn’t: rapidly sourcing oncology medication from the EU for a trial in South Korea Read all Rescuing a Global CRO's Oncology Trial with Lenvima How CSI has saved a leading global pharmaceutical company €1 million by sourcing pembrolizumab from the market at the best possible price Read all Delivering €1 million Savings for Pembrolizumab How CSI supplied large quantities of Jakavi to a Biotech’s ongoing Phase 3 oncology study involving 14 countries, nine depots and 67 site shipments Read all Global CRO Oncology Partnership Challenge ----- ------ ---- --P1-----forRichtext------------ Result ----- ------ ---- --P1-----forRichtext------------ Solution ----- ------ ---- --P1-----forRichtext------------ Case Study --- --- ---fORTitle --- --- ---- --- ----- ------ ----- ------- -- -- ------ - -forSubtitle --- ----- -- ------ ----- ------- -- -- --------- Challenge A leading pharmaceutical company reached out to CSI to source expensive comparators for their study running in China. Result CSI obtained all necessary approvals and licences, ensuring compliance with Chinese regulations and the smooth import of medicines into China. Solution CSI Successfully managed to obtain the First Leg Documents thanks to our longstanding relationship with manufacturer and this significantly reduced the risk of customs clearance issues, enabling timely entry of clinical trial supplies into China. Contact us Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements Company type Submit

How CSI leveraged relationships with multiple manufacturers to urgently supply large quantities of a generic drug to a global Phase 3 trial More case studies Ensuring batch-consistent, compliant comparator supply across NA, EU, and APAC - on time and uninterrupted. Read all Effective Sourcing of Semaglutide for a Global Phase III Clinical Trial From supply shortfall to on-time first-patient-first-visit across Europe, delivered in three days. Read all CSI's 72-hour Abraxane Rescue Mission Adaptive, multi-product supply across 22 countries and 80 sites, kept on time, in budget and compliant. Read all CSI’s Expert Delivery of a Global Respiratory Study A leading global biopharmaceutical company urgently requested CSI to supply the Fluarix QIV Southern Hemisphere Vaccine for 2025. Read all Rapid Sourcing of Discontinued Southern Hemisphere Vaccine for a Global Biopharmaceutical Client Securing reliable, cost-effective, long-term supply of Eylea PFS from EU and USA for a global biotech company’s clinical studies. Read all Securing Long-Term, Cost-Effective Supply of Eylea EU & USA for programs of studies A biotech client asked CSI to source Lucentis for a Phase II ophthalmology trial. Read all Comparator Sourcing for a Phase II Ophthalmology Study CSI Efficiently Delivered Venetoclax and Azacitidine Across 17 Countries Read all How CSI streamlined Venetoclax and Azacitidine supply across 17 countries in record time Export of expensive comparators from Europe to China with first leg documents and streamlined approach Read all CSI’s seamless comparator export to China CSI’s flexible approach to global distribution ensured a large CRO's five-year and three-year studies across a total of 18 countries could proceed without delay Read all Global Device Distribution How CSI rescued an oncology trial when a competitor failed to deliver, despite an extremely tight deadline and scarce supply on the market Read all Rescuing a Global CRO's Oncology Study with Cetuximab How CSI fulfilled what our competitors couldn’t: rapidly sourcing oncology medication from the EU for a trial in South Korea Read all Rescuing a Global CRO's Oncology Trial with Lenvima How CSI has saved a leading global pharmaceutical company €1 million by sourcing pembrolizumab from the market at the best possible price Read all Delivering €1 million Savings for Pembrolizumab Challenge ----- ------ ---- --P1-----forRichtext------------ Solution ----- ------ ---- --P1-----forRichtext------------ Result ----- ------ ---- --P1-----forRichtext------------ Case Study --- --- ---fORTitle --- --- ---- --- ----- ------ ----- ------- -- -- ------ - -forSubtitle --- ----- -- ------ ----- ------- -- -- --------- Challenge To supply a large quantity of a generic medication at the last minute for an ongoing Phase 3 clinical trial across three continents Solution A range of manufacturers were approached who could cover all trial countries, and clinical equivalency statements were successfully obtained Result CSI’s scientific expertise and knowledge of trial regulatory requirements delivered a strategy that enabled the client’s trial to begin without delay Contact us Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements Company type Submit

How CSI used its scientific expertise at the protocol stage to provide flexibility in sourcing strategy and ensure high volumes of a single product were supplied on time to multiple countries More case studies Ensuring batch-consistent, compliant comparator supply across NA, EU, and APAC - on time and uninterrupted. Read all Effective Sourcing of Semaglutide for a Global Phase III Clinical Trial From supply shortfall to on-time first-patient-first-visit across Europe, delivered in three days. Read all CSI's 72-hour Abraxane Rescue Mission Adaptive, multi-product supply across 22 countries and 80 sites, kept on time, in budget and compliant. Read all CSI’s Expert Delivery of a Global Respiratory Study A leading global biopharmaceutical company urgently requested CSI to supply the Fluarix QIV Southern Hemisphere Vaccine for 2025. Read all Rapid Sourcing of Discontinued Southern Hemisphere Vaccine for a Global Biopharmaceutical Client Securing reliable, cost-effective, long-term supply of Eylea PFS from EU and USA for a global biotech company’s clinical studies. Read all Securing Long-Term, Cost-Effective Supply of Eylea EU & USA for programs of studies A biotech client asked CSI to source Lucentis for a Phase II ophthalmology trial. Read all Comparator Sourcing for a Phase II Ophthalmology Study CSI Efficiently Delivered Venetoclax and Azacitidine Across 17 Countries Read all How CSI streamlined Venetoclax and Azacitidine supply across 17 countries in record time Export of expensive comparators from Europe to China with first leg documents and streamlined approach Read all CSI’s seamless comparator export to China CSI’s flexible approach to global distribution ensured a large CRO's five-year and three-year studies across a total of 18 countries could proceed without delay Read all Global Device Distribution How CSI rescued an oncology trial when a competitor failed to deliver, despite an extremely tight deadline and scarce supply on the market Read all Rescuing a Global CRO's Oncology Study with Cetuximab How CSI fulfilled what our competitors couldn’t: rapidly sourcing oncology medication from the EU for a trial in South Korea Read all Rescuing a Global CRO's Oncology Trial with Lenvima How CSI has saved a leading global pharmaceutical company €1 million by sourcing pembrolizumab from the market at the best possible price Read all Delivering €1 million Savings for Pembrolizumab Challenge ----- ------ ---- --P1-----forRichtext------------ Solution ----- ------ ---- --P1-----forRichtext------------ Result ----- ------ ---- --P1-----forRichtext------------ Case Study --- --- ---fORTitle --- --- ---- --- ----- ------ ----- ------- -- -- ------ - -forSubtitle --- ----- -- ------ ----- ------- -- -- --------- Challenge To supply grass pollen allergen tests for a global clinical trial in which no product was licensed in all trial countries and a considerable quantity of a single product was required Solution CSI researched an equivalent unlicensed product that was successfully submitted to all country regulators and could be sourced in large quantities from an independent manufacturer Result Engaging CSI at the protocol design stage allowed the sponsor flexibility in sourcing strategy, ensuring the supply of a high volume of a single product so the study could run to schedule Contact us Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements Company type Submit

A biotech client asked CSI to source Lucentis for a Phase II ophthalmology trial. More case studies Ensuring batch-consistent, compliant comparator supply across NA, EU, and APAC - on time and uninterrupted. Read all Effective Sourcing of Semaglutide for a Global Phase III Clinical Trial From supply shortfall to on-time first-patient-first-visit across Europe, delivered in three days. Read all CSI's 72-hour Abraxane Rescue Mission Adaptive, multi-product supply across 22 countries and 80 sites, kept on time, in budget and compliant. Read all CSI’s Expert Delivery of a Global Respiratory Study A leading global biopharmaceutical company urgently requested CSI to supply the Fluarix QIV Southern Hemisphere Vaccine for 2025. Read all Rapid Sourcing of Discontinued Southern Hemisphere Vaccine for a Global Biopharmaceutical Client Securing reliable, cost-effective, long-term supply of Eylea PFS from EU and USA for a global biotech company’s clinical studies. Read all Securing Long-Term, Cost-Effective Supply of Eylea EU & USA for programs of studies CSI Efficiently Delivered Venetoclax and Azacitidine Across 17 Countries Read all How CSI streamlined Venetoclax and Azacitidine supply across 17 countries in record time Export of expensive comparators from Europe to China with first leg documents and streamlined approach Read all CSI’s seamless comparator export to China CSI’s flexible approach to global distribution ensured a large CRO's five-year and three-year studies across a total of 18 countries could proceed without delay Read all Global Device Distribution How CSI rescued an oncology trial when a competitor failed to deliver, despite an extremely tight deadline and scarce supply on the market Read all Rescuing a Global CRO's Oncology Study with Cetuximab How CSI fulfilled what our competitors couldn’t: rapidly sourcing oncology medication from the EU for a trial in South Korea Read all Rescuing a Global CRO's Oncology Trial with Lenvima How CSI has saved a leading global pharmaceutical company €1 million by sourcing pembrolizumab from the market at the best possible price Read all Delivering €1 million Savings for Pembrolizumab How CSI supplied large quantities of Jakavi to a Biotech’s ongoing Phase 3 oncology study involving 14 countries, nine depots and 67 site shipments Read all Global CRO Oncology Partnership Request ----- ------ ---- --P1-----forRichtext------------ Challenge ----- ------ ---- --P1-----forRichtext------------ Solution ----- ------ ---- --P1-----forRichtext------------ Case Study --- --- ---fORTitle --- --- ---- --- ----- ------ ----- ------- -- -- ------ - -forSubtitle --- ----- -- ------ ----- ------- -- -- --------- Request The clinical trial proceeded without delays and the client acknowledged CSI’s contribution as instrumental in meeting their ambitious timelines Challenge Limited availability of high-demand drug Lucentis, need for batch consistency, regulatory compliance, and strict timelines. Solution CSI leveraged its global network to secure Lucentis, prioritized regulatory-aligned sourcing, ensured batch consistency, and optimized logistics for timely delivery. Contact us Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements Company type Submit

CSI specialises in supplying oncology products to global clinical trials all over the world, from generics to the most sophisticated cold chain biologics. The front line of research and clinical trials CSI specialises in supplying oncology products to clinical trials all over the world. Treatments for cancer have been advancing at an accelerated pace in recent years, resulting in significant clinical benefits and increased specificity through selection according to biomarkers or through engineered cell or gene therapies. Innovation is in our DNA, and we want to be part of your journey, helping you to advance your studies and improve patient outcomes with our clinical trial supply expertise. Oncology Products Oncology product sourcing specialists CSI has supplied oncology products to more than 1000 studies – from generics to the most sophisticated cold chain biologics. Pembrolizumab 50+ 1, 2, 3 Europe, USA Aflibercept 50+ 1, 2, 3 Europe, USA, Latin America Nivolumab 50+ 1, 2, 3 Global Ipilimumab 50+ 1, 2, 3 Global Ruxolitinib 25+ 2, 3 Global Biologic Number of Studies Phase of Trial Geography Keytruda (pembrolizumab) 50+ 1, 2, 3 Europe, USA Eylea (aflibercept) 50+ 1, 2, 3 Europe, USA, Latin America Opdivo (nivolumab) 50+ 1, 2, 3 Global Yervoy (ipilimumab) 50+ 1, 2, 3 Global Jakavi (ruxolitinib) 25+ 2, 3 Global Biologic Number of Studies Phase of Trial Geography CSI specialises in supplying oncology products to clinical trials all over the world. Treatments for cancer have been advancing at an accelerated pace in recent years, resulting in significant clinical benefits and increased specificity through selection according to biomarkers or through engineered cell or gene therapies. Innovation is in our DNA, and we want to be part of your journey, helping you to advance your studies and improve patient outcomes with our clinical trial supply expertise. Case Study Oncology Product Batch Hunting How CSI delivered mission impossible: sourcing specific tested batches of an expensive oncology product from several European markets Medicine Keytruda (pembrolizumab Eylea (aflibercept) Opdivo (nivolumab) Yervoy (ipilimumab) Jakavi (ruxolitinib) Number of Studies 50+ 50+ 50+ 50+ 25+ Phase of Trial 1, 2, 3 1, 2, 3 1, 2, 3 1, 2, 3 2, 3 Geography Europe, USA Europe, USA, Latin America Global Global Global Challenge To supply an oncology product for a client’s trial, with a caveat: a sample from each batch had to be tested before purchasing the bulk Outcome CSI’s high level of market knowledge resulted in the successful delivery of the required product and ensured the client’s trial never ran dry Solution We worked closely with suppliers to hunt specific batches in several European markets where batch visibility and documentation were possible We know our science There are many different types of targeted cancer drugs. These are categorised depending on how they work. Some drugs belong to more than one group because they work in more than one way. For example, a drug that works by blocking cancer cell growth may also be a monoclonal antibody. Some of these targeted drugs might also be called immunotherapies or biological therapies. Monoclonal Antibodies (MABs) Monoclonal antibodies (MABs) are a type of targeted drug therapy. They work by recognising and targeting specific proteins on cancer cells. There are many different MABs to treat cancer, and they work in different ways to kill the cancer cell or stop it from growing. Pertuzumab a treatment for breast cancer Bevacizumab a treatment for a number of different cancer types Rituximab a treatment for chronic lymphocytic leukaemia (CLL) and some types of non-Hodgkin lymphoma Cetuximab a treatment for advanced bowel cancer, and head and neck cancer Trastuzumab used to treat breast cancer and stomach cancer Ipilimumab and Nivolumab used together to treat a number of different cancer types Some MABs help the immune system to attack and kill cancer cells, so they are also a type of immunotherapy. Cancer Growth Blockers Cancer growth blockers are also called cancer growth inhibitors, and there are many different types. Our body makes chemicals called growth factors that control cell growth. Cancer growth blockers work by blocking the growth factors that trigger cancer cells to divide and grow. controls cell growth Epidermal growth factor (EGF) controls blood vessel development Vascular endothelial growth factor (VEGF) controls blood vessel development and cell growth Platelet derived endothelial growth factor (PDGF) controls cell growth Fibroblast growth factor (FGF) olaparib (Lynparza) rucaparib (Rubraca) niraparib (Zejula) PARP Inhibitors PARP inhibitors can be used to treat ovarian cancer and are currently in clinical trials for treatment of other types of cancer. PARP (poly-ADP ribose polymerase) is a protein found in our cells that helps damaged cells to repair themselves. As a cancer treatment, PARP inhibitors stop the PARP from repairing cancer cells, so the cell dies. Olaparib Rucaparib Niraparib Drugs that block blood vessel growth factor Some anti-angiogenics prevent vascular endothelial growth factor (VEGF) from attaching to the receptors on the cells that line the blood vessels. This stops the blood vessels from growing. One drug that blocks VEGF is bevacizumab (Avastin), which is also a monoclonal antibody. It is a treatment for several different types of cancer. Bevacizumab Aflibercept Ramucirumab Anti-Angiogenics Anti-angiogenic drugs are treatments that stop cancer tumours from growing their own blood vessels, slowing their growth and sometimes shrinking them. There are different types of anti-angiogenic drugs, which work in different ways. Checkpoint Inhibitors Checkpoint inhibitors are a type of immunotherapy. They are a treatment for cancers such as melanoma skin cancer and lung cancer. These drugs block different checkpoint proteins. You might also hear them named after these checkpoint proteins: CTLA-4 inhibitors, PD-1 inhibitors and PD-L1 inhibitors. Pembrolizumab Ipilimumab Nivolumab Atezolizumab Avelumab Advances in cancer therapeutics Over the past five years, 61 cancer drugs, each approved in one or more tumours, have impacted the treatment of 23 different cancer types. The rise of immuno-oncology since 2014 has been largely centred on the PD-1 and PD-L1 mechanisms – so-called checkpoint inhibitors – which have broad efficacy across solid tumours and are used across 23 different tumour types. The range of clinical benefits from this new group of medicines includes several with total remission rates above 50% and significant extensions of overall survival, as well as some with incremental survival benefits in tumours where those rates were already extremely high. Monoclonal Antibodies (MABs) Monoclonal antibodies (MABs) are a type of targeted drug therapy. They work by recognising and targeting specific proteins on cancer cells. There are many different MABs to treat cancer, and they work in different ways to kill the cancer cell or stop it from growing. Pipeline for clinical development More than 1000 cancer drugs are in late-stage development – up over 60% from a decade ago. Over one third of these clinical trials are using biomarkers to stratify patients, pointing to even more personalised and effective cancer treatments in the future. At CSI, we design supply chains to minimise wastage and ensure sites have the medication they need, precisely when they need it. We proactively manage your study’s supplies and can deliver significant savings. Axitinib Dasatinib Erlotinib Imatinib Nilotinib Pazopanib Sunitinib Bortezomib Drugs that block signalling within the cell Some drugs stop the VEGF receptors from sending growth signals into the blood vessel cells. These treatments are also called cancer growth blockers or tyrosine kinase inhibitors (TKIs). Sunitinib Sorafenib Axitinib Regorafenib Cabozantinib Contact us Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements Company type Submit

CSI Efficiently Delivered Venetoclax and Azacitidine Across 17 Countries More case studies Ensuring batch-consistent, compliant comparator supply across NA, EU, and APAC - on time and uninterrupted. Read all Effective Sourcing of Semaglutide for a Global Phase III Clinical Trial From supply shortfall to on-time first-patient-first-visit across Europe, delivered in three days. Read all CSI's 72-hour Abraxane Rescue Mission Adaptive, multi-product supply across 22 countries and 80 sites, kept on time, in budget and compliant. Read all CSI’s Expert Delivery of a Global Respiratory Study A leading global biopharmaceutical company urgently requested CSI to supply the Fluarix QIV Southern Hemisphere Vaccine for 2025. Read all Rapid Sourcing of Discontinued Southern Hemisphere Vaccine for a Global Biopharmaceutical Client Securing reliable, cost-effective, long-term supply of Eylea PFS from EU and USA for a global biotech company’s clinical studies. Read all Securing Long-Term, Cost-Effective Supply of Eylea EU & USA for programs of studies A biotech client asked CSI to source Lucentis for a Phase II ophthalmology trial. Read all Comparator Sourcing for a Phase II Ophthalmology Study Export of expensive comparators from Europe to China with first leg documents and streamlined approach Read all CSI’s seamless comparator export to China CSI’s flexible approach to global distribution ensured a large CRO's five-year and three-year studies across a total of 18 countries could proceed without delay Read all Global Device Distribution How CSI rescued an oncology trial when a competitor failed to deliver, despite an extremely tight deadline and scarce supply on the market Read all Rescuing a Global CRO's Oncology Study with Cetuximab How CSI fulfilled what our competitors couldn’t: rapidly sourcing oncology medication from the EU for a trial in South Korea Read all Rescuing a Global CRO's Oncology Trial with Lenvima How CSI has saved a leading global pharmaceutical company €1 million by sourcing pembrolizumab from the market at the best possible price Read all Delivering €1 million Savings for Pembrolizumab How CSI supplied large quantities of Jakavi to a Biotech’s ongoing Phase 3 oncology study involving 14 countries, nine depots and 67 site shipments Read all Global CRO Oncology Partnership Request ----- ------ ---- --P1-----forRichtext------------ Challenge ----- ------ ---- --P1-----forRichtext------------ Solution ----- ------ ---- --P1-----forRichtext------------ Case Study --- --- ---fORTitle --- --- ---- --- ----- ------ ----- ------- -- -- ------ - -forSubtitle --- ----- -- ------ ----- ------- -- -- --------- Request CSI was entrusted with sourcing large quantities of Venetoclax and Azacitidine for a study spanning 17 countries and three continents. Challenge The client faced a tight six-month enrollment deadline and required Certificates of Analysis (CoA) for a complex study. Solution CSI utilized its partnerships to halve approval times, reduce supply lead times from four months to four weeks and ensure timely delivery with all required documentation. Contact us Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements Company type Submit

How CSI has saved a leading global pharmaceutical company €1 million by sourcing pembrolizumab from the market at the best possible price More case studies Ensuring batch-consistent, compliant comparator supply across NA, EU, and APAC - on time and uninterrupted. Read all Effective Sourcing of Semaglutide for a Global Phase III Clinical Trial From supply shortfall to on-time first-patient-first-visit across Europe, delivered in three days. Read all CSI's 72-hour Abraxane Rescue Mission Adaptive, multi-product supply across 22 countries and 80 sites, kept on time, in budget and compliant. Read all CSI’s Expert Delivery of a Global Respiratory Study A leading global biopharmaceutical company urgently requested CSI to supply the Fluarix QIV Southern Hemisphere Vaccine for 2025. Read all Rapid Sourcing of Discontinued Southern Hemisphere Vaccine for a Global Biopharmaceutical Client Securing reliable, cost-effective, long-term supply of Eylea PFS from EU and USA for a global biotech company’s clinical studies. Read all Securing Long-Term, Cost-Effective Supply of Eylea EU & USA for programs of studies A biotech client asked CSI to source Lucentis for a Phase II ophthalmology trial. Read all Comparator Sourcing for a Phase II Ophthalmology Study CSI Efficiently Delivered Venetoclax and Azacitidine Across 17 Countries Read all How CSI streamlined Venetoclax and Azacitidine supply across 17 countries in record time Export of expensive comparators from Europe to China with first leg documents and streamlined approach Read all CSI’s seamless comparator export to China CSI’s flexible approach to global distribution ensured a large CRO's five-year and three-year studies across a total of 18 countries could proceed without delay Read all Global Device Distribution How CSI rescued an oncology trial when a competitor failed to deliver, despite an extremely tight deadline and scarce supply on the market Read all Rescuing a Global CRO's Oncology Study with Cetuximab How CSI fulfilled what our competitors couldn’t: rapidly sourcing oncology medication from the EU for a trial in South Korea Read all Rescuing a Global CRO's Oncology Trial with Lenvima How CSI supplied large quantities of Jakavi to a Biotech’s ongoing Phase 3 oncology study involving 14 countries, nine depots and 67 site shipments Read all Global CRO Oncology Partnership Challenge ----- ------ ---- --P1-----forRichtext------------ Solution ----- ------ ---- --P1-----forRichtext------------ Result ----- ------ ---- --P1-----forRichtext------------ Case Study --- --- ---fORTitle --- --- ---- --- ----- ------ ----- ------- -- -- ------ - -forSubtitle --- ----- -- ------ ----- ------- -- -- --------- Challenge To source large quantities of an expensive oncology drug for a pharmaceutical company at a price much lower than that offered by the manufacturer Solution CSI leveraged its network of reliable suppliers to present sourcing options to the client that demonstrated a considerable discount Result Our client has been supplied with pembrolizumab consistently for the past couple of years, saving €1 million thanks to CSI’s sourcing solutions Contact us Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements Company type Submit